Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.

Oto, Yuji; Tanaka, Yuriko; Abe, Yoshiko; Obata, Kazuo; Tsuchiya, Takayoshi; Yoshino, Atsunori; Murakami, Nobuyuki; Nagai, Toshiro

Oto, Yuji; Tanaka, Yuriko; Abe, Yoshiko; Obata, Kazuo; Tsuchiya, Takayoshi; Yoshino, Atsunori; Murakami, Nobuyuki; Nagai, Toshiro.

Affiliation

Oto Y; Department of Pediatrics, Dokkyo Medical University, Koshigaya Hospital, Saitama, Japan.

Am J Med Genet A ; 164A(3): 671-5, 2014 Mar.

Article in En | MEDLINE | ID: mdl-24443368

Subject(s)

Body Mass Index; Hormone Replacement Therapy; Human Growth Hormone/therapeutic use; Obesity/etiology; Prader-Willi Syndrome/complications; Prader-Willi Syndrome/drug therapy; Withholding Treatment; Adiposity; Body Weights and Measures; Female; Human Growth Hormone/administration & dosage; Humans; Male; Prader-Willi Syndrome/genetics; Retrospective Studies; Time Factors

Key words

BMI; Prader-Willi syndrome; adipose tissue distribution; cessation; growth hormone therapy; subcutaneous adipose tissue; visceral adipose tissue

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prader-Willi Syndrome / Body Mass Index / Human Growth Hormone / Hormone Replacement Therapy / Withholding Treatment / Obesity Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Am J Med Genet A Journal subject: GENETICA MEDICA Year: 2014 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google